Evidence of Intratumoral Localization, Activation, and Immunomodulatory Effect of CX-072, a PROBODY Therapeutic Targeting PD-L1, in a Phase 1/2 Trial

Susan K. Lyman, Aung Naing, Ivan A. Zein, Yuanbin Ru, Bruce Howng, Michael B. Winter, Olga Vasiljeva, Will Garner, Beiyao Zheng, Mark Stroh, Hong Lu, Jennifer Richardson, W. Michael Kavanaugh, Luc R. Desnoyers. Poster presented at the ASCO20 Virtual Scientific Program, May 29-31, 2020.